Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Scancell PLC in collaboration talks after funding, says joint chief

Immunotherapy group Scancell PLC (LON:SCLP)  saw strong support from institutions for its fundraise to develop its two lead platform technologies.

Richard Goodfellow, joint chief executive, tells Proactive the funds will be split between its vaccine platform, Immunobody, and its pre-clinical peptide-based vaccine platform Moditope.

He adds that the company is “talking to a range of companies about a whole range of projects and you can expect to hear about the progress on various forms of collaborations over the course of this year.”

 
Meet Acal Plc and Scancell Holdings Plc at our event, London, 07 July 2016. Register here »
View full SCLP profile

Scancell Holdings Plc Timeline

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.